Arcus Biosciences (RCUS) Tax Provisions (2021 - 2024)

Arcus Biosciences' Tax Provisions history runs 4 years deep, the most recent figure standing at $1.0 million for Q4 2024.

• In Q4 2024, Tax Provisions changed 0.0% year-over-year to $1.0 million; the TTM figure through Sep 2025 stood at $1.0 million (changed 0.0% YoY), while the FY2024 annual figure was $1.0 million, down 83.33% from the prior year.
• Tax Provisions was $1.0 million for Q4 2024 at Arcus Biosciences, roughly flat from $1.0 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $2.0 million in Q4 2021 to a low of $1.0 million in Q1 2022.
• Historically, Tax Provisions has averaged $1.4 million across 4 years, with a median of $1.0 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Tax Provisions surged 100.0% in 2023, then changed 0.0% in 2024.
• A 4-year view of Tax Provisions shows it stood at $2.0 million in 2021, then tumbled by 50.0% to $1.0 million in 2022, then changed by 0.0% to $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024.
• The last three Tax Provisions figures came in at $1.0 million (Q4 2024), $1.0 million (Q4 2023), and $2.0 million (Q3 2023), per Business Quant data.